March 04, 2015 5:45 PM ET

Pharmaceuticals

Company Overview of Caliber Therapeutics, Inc.

Company Overview

Caliber Therapeutics, Inc. engages in the development and commercialization of minimally-invasive balloon-based drug delivery products for the intervention of atherosclerotic diseases. It offers Targeted Angioplasty Drug Delivery balloon, a stent-free delivery platform of anti-restenotic drugs, which enables controlled and targeted drug delivery, reduces thrombosis risk, and reduces the need to implant permanent devices. Caliber Therapeutics, Inc. is based in Monmouth Junction, New Jersey.

11 Deer Park Drive

Suite 208

Princeton, NJ 08852

United States

Phone:

732-329-0297

Fax:

732-329-0298

Key Executives for Caliber Therapeutics, Inc.

Founder and Chief Scientific Officer
Chief Medical Officer
Vice President of Product Development
Director of Analytical Biochemistry
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Zuellig Group N.A., Inc. United States
Amira Pharmaceuticals, Inc. United States
Migranade, Inc. United States
OSI Pharmaceuticals Inc. United States
ALZA Pharmaceuticals United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Caliber Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.